ChromaDex
Data Breaches, Cyber Attacks and Security Report

https://chromadex.com  ᛫  Business Services
Last updated November 12, 2019

About ChromaDex

Company Overview

ChromaDex is a dietary supplement and food ingredient company based in Irvine, California founded in 1999 that is publicly traded on the NASDAQ. ChromaDex has licensed patents from the University of Mississippi and the USDA to commercially develop pterostilbene and sell the compound trademarked as pTeroPure via the company's BluScience product line. In 2011, Cornell University announced it granted ChromaDex exclusive worldwide rights to a novel manufacturing process for nicotinamide riboside which it markets and sells as an ingredient under the brand name Niagen.ChromaDex also offers contract research services that help customers source raw materials, identify new compounds and develop processes for large scale manufacturing.As of 2012 American billionaire and pharmaceutical entrepreneur Phillip Frost owned approximately 19% of ChromaDex.ChromaDex sells ingredients to third parties that market them under their own labels.

Valuation

Employees

CEO

Robert Fried

Location

Data Breaches and Security News

ChromaDex Security Rating

Sorry, this security report couldn't be loaded at this time. Please try again later.

UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely ChromaDex is implementing good security practices.

Passed Checks

Passed{{ passedCheck.passTitle }}

Failed Checks

Warning{{ failedCheck.failTitle }}

View a free security report for ChromaDex

Get full security report ›

Related posts

Read more about the latest issues in cybersecurity

More security reports

Compare ChromaDex's security performance with other companies